Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index; 36 of the 44 sources its claims cite were checked for support.

In Candida glabrata, ERMES Component GEM1 Controls Mitochondrial Morphology, mtROS, and Drug Efflux Pump Expression, Resulting in Azole Susceptibility

Open access

Abstract

Mitochondrial dysfunction or morphological abnormalities in human pathogenic fungi are known to contribute to azole resistance; however, the underlying molecular mechanisms are unknown. In this study, we investigated the link between mitochondrial morphology and azole resistance in Candida glabrata, which is the second most common cause of human candidiasis worldwide. The ER-mitochondrial encounter structure (ERMES) complex is thought to play an important role in the mitochondrial dynamics necessary for mitochondria to maintain their function. Of the five components of the ERMES complex, deletion of GEM1 increased azole resistance. Gem1 is a GTPase that regulates the ERMES complex activity. Point mutations in GEM1 GTPase domains were sufficient to confer azole resistance. The cells lacking GEM1 displayed abnormalities in mitochondrial morphology, increased mtROS levels, and increased expression of azole drug efflux pumps encoded by CDR1 and CDR2. Interestingly, treatment with N-acetylcysteine (NAC), an antioxidant, reduced ROS production and the expression of CDR1 in Δgem1 cells. Altogether, the absence of Gem1 activity caused an increase in mitochondrial ROS concentration, leading to Pdr1-dependent upregulation of the drug efflux pump Cdr1, resulting in azole resistance.

Overview

CoChat Summary

## TL;DR

This study shows that deleting GEM1 in *Candida glabrata* increases fluconazole/azole resistance, but only when other ERMES components remain functional. The resistance is linked to abnormal mitochondrial morphology, increased mitochondrial ROS, and Pdr1-dependent CDR1 upregulation.

## Key findings

  • Deleting GEM1 increased azole resistance, while deletion of MDM12, MDM34, or MMM1 caused growth defects; in Δgem1 Δmdm10/Δmdm12/Δmdm34 strains, the azole-resistance phenotype was abolished.
  • In Δgem1 cells, CDR1 mRNA was upregulated to about 4-fold higher than in Δmdm12 cells; CDR2 was also upregulated, while PDR1 mRNA was virtually unchanged.
  • N-acetylcysteine (NAC) reduced mtROS in Δgem1 cells after 24 or 40 h and also decreased CDR1 expression, supporting a ROS-linked mechanism.
  • Gem1 point mutants in the GTPase domains (T19A and S452A) did not complement the azole-resistance phenotype, whereas E216A and E344A in the EF-hand motifs did.

## Methods

  • Yeast strains of *C. glabrata* were grown in YPD or SD medium at 30 °C or 37 °C; single and double deletion mutants of ERMES genes and GEM1 point mutants were constructed by homologous recombination/site-directed mutagenesis.
  • Azole susceptibility and mitochondrial morphology were assessed by growth assays and fluorescence microscopy using MitoBright LT Red, MitoTracker Red CM-H2XROS, and tagged proteins such as Mdm34-mCherry and GFP-Gem1.
  • qRT-PCR measured CDR1, CDR2, and PDR1 transcript levels, normalized to TEF1.

## Limitations

  • The paper states that it is not known whether oxidative stress or mtROS regulates Pdr1 activation, and says further analysis of Δgem1 cells is needed.
  • The text suggests a limitation of mechanism: while the study links GEM1 loss → mtROS → CDR1/PDR1-related resistance, it does not directly establish the molecular step connecting mtROS to Pdr1 activation (evident from the discussion).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jof9020240

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Resistance to azoles by deletion of GEM1. (A) Schematic diagram of the ERMES complex, based on a report in S. cerevisiae. OM, outer membrane. IM, inner membrane. (B) Growth of strains lacking ERMES components (Δmdm12, Δmdm34, Δmdm10, Δmmm1, and Δgem1) in the presence or absence of fluconazole. The cells were diluted to OD600 (optical density at 600 nm) of 0.5 in water and spotted in 4-fold serial dilutions (indicated by triangles) on agar plates of minimal SD medium containing the indicated concentration of fluconazole. All cells except for Δmmm1 cells were incubated for 2 days (upper panel), and Δmmm1 cells were incubated for 3 days at 30 °C or 37 °C. (C) Growth of strains lacking ERMES components on the plate containing glycerol as the carbon source. The cells were spotted in 4-fold serial dilutions on the minimum medium containing glucose or 3% glycerol and incubated for 3 days at 30 °C.
Figure 1 Resistance to azoles by deletion of GEM1. (A) Schematic diagram of the ERMES complex, based on a report in S. cerevisiae. OM, outer membrane. IM, inner membrane. (B) Growth of strains lacking ERMES components (Δmdm12, Δmdm34, Δmdm10, Δmmm1, and Δgem1) in the presence or absence of fluconazole. The cells were diluted to OD600 (optical density at 600 nm) of 0.5 in water and spotted in 4-fold serial dilutions (indicated by triangles) on agar plates of minimal SD medium containing the indicated concentration of fluconazole. All cells except for Δmmm1 cells were incubated for 2 days (upper panel), and Δmmm1 cells were incubated for 3 days at 30 °C or 37 °C. (C) Growth of strains lacking ERMES components on the plate containing glycerol as the carbon source. The cells were spotted in 4-fold serial dilutions on the minimum medium containing glucose or 3% glycerol and incubated for 3 days at 30 °C.CC BY · PubMed Central
Figure 2 Mitochondrial morphology in Δgem1 and Δmdm34 cells. Exponentially growing cells were incubated at 37 °C in minimum SD medium, stained with MitoBright LT Red, and observed by fluorescence microscopy. The percentage of cells with the indicated mitochondrial morphology for each strain is shown in the bar graph (n = 200). Scale bar, 5 µm.
Figure 2 Mitochondrial morphology in Δgem1 and Δmdm34 cells. Exponentially growing cells were incubated at 37 °C in minimum SD medium, stained with MitoBright LT Red, and observed by fluorescence microscopy. The percentage of cells with the indicated mitochondrial morphology for each strain is shown in the bar graph (n = 200). Scale bar, 5 µm.CC BY · PubMed Central
Figure 3 Involvement of CDR genes in fluconazole resistance in Δgem1 cells. (A) Quantitative RT-PCR for CDR1, CDR2, and PDR1 in wild-type, Δgem1, and Δmdm12 cells. The cells were exponentially incubated at 37 °C in minimal SD medium. Data were normalized to the corresponding levels of the housekeeping transcript (TEF1), and the expression levels of WT were set at a relative expression of 1. Values are presented as the mean ± standard error of 3 independent experiments. (B) Growth of PDR gene mutants in fluconazole medium. Indicated cells were spotted in 4-fold serial dilutions, as indicated by triangles, on agar plates of minimal SD medium containing fluconazole at the indicated concentrations. The cells were incubated at 37 °C in minimal SD medium for 3 days. p-values of the t-test vs. wild-type are as follows: * p < 0.05, ** p < 0.01.
Figure 3 Involvement of CDR genes in fluconazole resistance in Δgem1 cells. (A) Quantitative RT-PCR for CDR1, CDR2, and PDR1 in wild-type, Δgem1, and Δmdm12 cells. The cells were exponentially incubated at 37 °C in minimal SD medium. Data were normalized to the corresponding levels of the housekeeping transcript (TEF1), and the expression levels of WT were set at a relative expression of 1. Values are presented as the mean ± standard error of 3 independent experiments. (B) Growth of PDR gene mutants in fluconazole medium. Indicated cells were spotted in 4-fold serial dilutions, as indicated by triangles, on agar plates of minimal SD medium containing fluconazole at the indicated concentrations. The cells were incubated at 37 °C in minimal SD medium for 3 days. p-values of the t-test vs. wild-type are as follows: * p < 0.05, ** p < 0.01.CC BY · PubMed Central
Figure 4 Domain structure of Gem1 and the effects of domain mutations on azole susceptibility. (A) Schematic diagram of Gem1, containing 2 putative GTPase domains (GTPase I and II), 2 EF-hand motifs (EF-hand I and II), and a transmembrane domain (TM). The positions indicated by arrows indicate the amino acid substitution sites. (B) Sequence alignment of the predicted GTP-binding domain (G1 motif) and EF-hand motifs of Gem1 from C. glabrata, S. cerevisiae, C. albicans, and their human ortholog, MIRO1 (hMiro1). The characters in the red frame indicate the mutated residues in this study. (C) Localization of mutant Gem1 harboring a mutation in the GTPase domain or Ca2+- binding domain. Δgem1 cells expressing the indicated GFP-tagged mutant Gem1 under the control of the GEM1 promoter and Mdm34-mCherry were incubated at 30 °C in SC-Ura medium and observed by confocal microscopy. White arrowheads indicate colocalization between Gem1 and Mdm34. Black arrowheads indicate that Gem1 was not localized in ERMES. Scale bar, 5 µm. (D) Δgem1 cells, which were transformed with pGRB2.0, pGRB-GFP-GEM1, pGRB-GFP-gem1(T19A), pGRB-GFP-gem1 (E216A), pGRB-GFP-gem1 (E344A), or pGRB-GFP-gem1(S452A), were incubated at 30 °C in SC-Ura medium for 1 day and the optical density (OD) at 600 nm was measured. Relative growth was determined by normalizing to OD600 without fluconazole. Error bars represent standard errors of 3 independent experiments. p-values of the t-test against the without FCZ vs. follows: * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 4 Domain structure of Gem1 and the effects of domain mutations on azole susceptibility. (A) Schematic diagram of Gem1, containing 2 putative GTPase domains (GTPase I and II), 2 EF-hand motifs (EF-hand I and II), and a transmembrane domain (TM). The positions indicated by arrows indicate the amino acid substitution sites. (B) Sequence alignment of the predicted GTP-binding domain (G1 motif) and EF-hand motifs of Gem1 from C. glabrata, S. cerevisiae, C. albicans, and their human ortholog, MIRO1 (hMiro1). The characters in the red frame indicate the mutated residues in this study. (C) Localization of mutant Gem1 harboring a mutation in the GTPase domain or Ca2+- binding domain. Δgem1 cells expressing the indicated GFP-tagged mutant Gem1 under the control of the GEM1 promoter and Mdm34-mCherry were incubated at 30 °C in SC-Ura medium and observed by confocal microscopy. White arrowheads indicate colocalization between Gem1 and Mdm34. Black arrowheads indicate that Gem1 was not localized in ERMES. Scale bar, 5 µm. (D) Δgem1 cells, which were transformed with pGRB2.0, pGRB-GFP-GEM1, pGRB-GFP-gem1(T19A), pGRB-GFP-gem1 (E216A), pGRB-GFP-gem1 (E344A), or pGRB-GFP-gem1(S452A), were incubated at 30 °C in SC-Ura medium for 1 day and the optical density (OD) at 600 nm was measured. Relative growth was determined by normalizing to OD600 without fluconazole. Error bars represent standard errors of 3 independent experiments. p-values of the t-test against the without FCZ vs. follows: * p < 0.05, ** p < 0.01, *** p < 0.001.CC BY · PubMed Central
Figure 5 Mitochondrial ROS production in Δgem1 cells. (A) Detection of intracellular mitochondrial ROS (mtROS). Wild-type and Δgem1 cells expressing Tom70-GFP were cultivated in minimal SD medium until the exponential growth phase at 30 °C. The cells were stained with MitoTracker Red CM-H2XROS, washed, and observed using fluorescence microscopy. Tom70 was used as a mitochondrial marker. Arrowheads indicate cells in which mitochondria were present but not stained by MitoTracker Red CM-H2XROS. Δgem1 cells contained approximately 29% cells (n = 310) that were not stained by MitoTracker or weakly stained. Scale bar, 5 µm. (B) Effect of N-acetylcysteine (NAC) on ROS production in Δgem1 cells. Δgem1 cells were grown in SD medium with (+NAC) or without 10 mM NAC (–NAC) at 30 °C for 24 or 40 h and then stained with MitoTracker Red. (C) Effect of NAC on CDR1 expression level in Δgem1 cells. Δgem1 cells were exponentially incubated in SD medium with (+NAC) or without 10 mM NAC (–NAC) at 30 °C for 40 h. CDR1 expression level was analyzed by quantitative RT-PCR and normalized to the corresponding levels of the housekeeping transcript, TEF1. Error bars represent standard errors of 3 independent experiments. The p-value of the t-test is less than 0.001.
Figure 5 Mitochondrial ROS production in Δgem1 cells. (A) Detection of intracellular mitochondrial ROS (mtROS). Wild-type and Δgem1 cells expressing Tom70-GFP were cultivated in minimal SD medium until the exponential growth phase at 30 °C. The cells were stained with MitoTracker Red CM-H2XROS, washed, and observed using fluorescence microscopy. Tom70 was used as a mitochondrial marker. Arrowheads indicate cells in which mitochondria were present but not stained by MitoTracker Red CM-H2XROS. Δgem1 cells contained approximately 29% cells (n = 310) that were not stained by MitoTracker or weakly stained. Scale bar, 5 µm. (B) Effect of N-acetylcysteine (NAC) on ROS production in Δgem1 cells. Δgem1 cells were grown in SD medium with (+NAC) or without 10 mM NAC (–NAC) at 30 °C for 24 or 40 h and then stained with MitoTracker Red. (C) Effect of NAC on CDR1 expression level in Δgem1 cells. Δgem1 cells were exponentially incubated in SD medium with (+NAC) or without 10 mM NAC (–NAC) at 30 °C for 40 h. CDR1 expression level was analyzed by quantitative RT-PCR and normalized to the corresponding levels of the housekeeping transcript, TEF1. Error bars represent standard errors of 3 independent experiments. The p-value of the t-test is less than 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

23 Valid · 2 Not valid · 1 Not checked · 43 Own results and interpretations

37 more claims

Create a free account to see all 69 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Citations

Cites

Show all 53 references

Cited by

See all 11

Metadata

Authors
Okamoto, M., Nakano, K., Takahashi-Nakaguchi, A., Sasamoto, K., Yamaguchi, M., Teixeira, M. C., & Chibana, H.
Affiliations
  • Chiba University (JP)
  • Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan
  • University of Lisbon (PT)
Corresponding author
Chibana, Hiroji
Venue
Journal of Fungi
Publisher
MDPI AG
Published
2023-02-10
Volume
9
Issue
2
Pages
240
ISSN
2309-608X (ISSN-L)
OpenAlex
W4320492640
Cited by
11
References
53
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 2
FWCI
2.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Fungi (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • JSPS KAKENHI (20K07475, 18H02653)
  • Hamaguchi Foundation (20K07475, 18H02653)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
Candida glabrata, ERMES complex, mitochondrial morphology, mitochondrial reactive oxygen species, azole resistance, drug efflux pumps, CDR1, CDR2, PDR1, N-acetylcysteine, GTPase, mitochondrial dynamics, candidiasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Candida glabrata, ERMES Component GEM1 Controls Mitochondrial Morphology, mtROS, and Drug Efflux Pump Expression, Resulting in Azole Susceptibility. https://app.cochat.ai/papers/10.3390/jof9020240
The paper
Okamoto, M., Nakano, K., Takahashi-Nakaguchi, A., Sasamoto, K., Yamaguchi, M., Teixeira, M. C., & Chibana, H. (2023). In Candida glabrata, ERMES Component GEM1 Controls Mitochondrial Morphology, mtROS, and Drug Efflux Pump Expression, Resulting in Azole Susceptibility. Journal of Fungi. https://doi.org/10.3390/jof9020240

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.